InflaRx inflarx.com


InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. InflaRx focuses on the development of first-in-class monoclonal antibodies targeting activation products of the complement system for application in life threatening inflammatory diseases and certain organ drug ...Show all

InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeu...Show all

Company (Alive / Active)

Phone: (0)3641-508180

Fax:

Winzerlaer Str. 2

Jena, D-07745
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
InflaRx $34M Jul 21, 2016
Intarcia Therapeutics $1204.1M Sep 15, 2016
ARYX Therapeutics $132M Nov 5, 2008
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related InflaRx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-c5a binding moieties with high blocking activity Jun 03, 2015 Oct 04, 2016 Patent
Anti-c5a binding moieties with high blocking activity Jun 27, 2014 Jul 07, 2015 Patent
Anti-c5a binding antibodies with high block activity Nov 26, 2010 Aug 12, 2014 Patent